Bill > HR2435

This bill amends the Federal Food, Drug, and Cosmetic Act to make several changes to the Reagan-Udall Foundation for the Food and Drug Administration, a non-profit organization established to support the FDA's mission. Key provisions include allowing the Foundation's Board of Directors to increase its size beyond 14 voting members, with new members appointed by existing board members and a limit of 30% of the total board representing specific industries like pharmaceuticals and food; clarifying that Federal Government employees can serve on the board, excluding "special Government employees"; and establishing a standard 4-year term for board members, with provisions for staggered terms for initial appointments to ensure continuity. Additionally, the bill removes the restriction that the Executive Director's compensation cannot exceed that of the FDA Commissioner, and it changes how funds are managed, requiring them to be managed as individual programmatic funds under specific provisions, adhering to best accounting practices, rather than being held in separate accounts from certain other funds.